OKSANA MCFALL: Open Payments
NPI 1326787508 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 25 payments from 6 companies in 2025. Trend: 2023 $190 · 2024 $868 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $276 |
| Vanda Pharmaceuticals Inc. | 6 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Lundbeck LLC | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: VRAYLAR, FANAPT, HETLIOZ, CAPLYTA, REXULTI, TRINTELLIX, Auvelity.
Industry payments across AZ — which companies pay providers there.
